Choice of hypomethylating agent (HMA) for initial treatment does not influence outcome or survival for therapy-related myeloid neoplasms (t-MN) Meeting Abstract
| Authors: | Kabel, C. C.; Goldman, D. A.; Buie, L. W.; Klimek, V. M. |
| Abstract Title: | Choice of hypomethylating agent (HMA) for initial treatment does not influence outcome or survival for therapy-related myeloid neoplasms (t-MN) |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Language: | English |
| ACCESSION: | WOS:000577160402270 |
| DOI: | 10.1182/blood-2019-129129 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1718 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
